Zhejiang Anglikang Pharmaceutical Co.,Ltd.’s Net Profit Rose 24.2% in First Three Quarters of 2023

Zhejiang Anglikang Pharmaceutical Co.,Ltd. (浙江昂利康制药股份有限公司) (002940.SZ) reported a net profit of 140.9 million yuan in the first three quarters of 2023, up 24.2% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, up 11.7% year-on-year.

At the end of the reporting period, it had 3.2 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 43.5%.